Stock scanner
Ready-made scans
Fastest expected revenue growth under $2BCheap and profitableDividend payersNear their 52-week highBeaten down, finances improvingReporting this week
Filters
5,450 US-listed companies, filtered by valuation, profitability, growth, analysts' forecasts and momentum. Prices are from the October 9 close; company figures refresh weekly.
This data is 11 days old: the nightly update hasn't run since October 10.
The scanner turns your question into filters, and the results come straight from the data. The filters it chose show below, to check or change. You get 3 free questions a month.
5,450 companies match
| Company | Mkt cap | Price | P/E | EV/Sales | P/B | Yield | Net margin | ROIC | Rev growth | 1Y |
|---|---|---|---|---|---|---|---|---|---|---|
| RGNXREGENXBIO Inc. | $417M | $8.07 | loss | 2.6 | 5.9 | 0.0% | −113% | −52.7% | 12.0% | −26.1% |
| NGNENeurogene Inc. | $417M | $26.40 | loss | — | 2.7 | 0.0% | — | −53.7% | — | −12.6% |
| NATHNathan's Famous, Inc. | $417M | $101.77 | 20.9 | 2.6 | neg. eq. | 3.9% | 11.8% | 47.1% | 12.4% | −2.6% |
| CICCCION Investment Corp. 7.5 % Notes 2026-31.03.31 | $417M | $24.30 | — | — | — | 1.9% | — | — | — | −2.5% |
| ACCOACCO Brands Corporation | $414M | $4.49 | 7.1 | 0.8 | 0.6 | 6.7% | 3.7% | 3.8% | −0.6% | +20.4% |
| TCITranscontinental Realty Investors, Inc. | $413M | $47.75 | 51.4 | 12.1 | 0.5 | 0.0% | 15.9% | −0.6% | 10.8% | +8.0% |
| AVIRAtea Pharmaceuticals, Inc. | $412M | $5.15 | loss | — | 2.0 | 0.0% | — | −86.4% | — | +64.0% |
| VALUValue Line, Inc. | $412M | $43.88 | 20.8 | 12.1 | 3.8 | 3.1% | 60.3% | 2.0% | −5.5% | +14.1% |
| ALLTAllot Ltd. | $410M | $8.39 | 38.5 | 3.7 | 3.5 | 0.0% | 9.4% | 4.7% | 14.3% | −14.9% |
| OPRTOportun Financial Corporation | $409M | $8.92 | 22.3 | n/a | 1.1 | 0.0% | 2.8% | n/a | 12.0% | +75.2% |
| MAGNMagnera Corp | $409M | $11.50 | loss | 0.6 | 0.4 | 0.0% | −3.4% | 3.7% | 21.8% | +15.7% |
| LANDGladstone Land Corporation | $409M | $9.48 | loss | 9.9 | 0.6 | 5.9% | −7.3% | 66.4% | 21.6% | +5.2% |
| MYGNMyriad Genetics, Inc. | $407M | $4.31 | loss | 0.6 | 1.3 | 0.0% | −14.0% | −19.1% | −3.2% | −42.5% |
| CALCaleres, Inc. | $406M | $12.09 | 7.5 | 0.4 | 0.6 | 2.3% | 1.8% | 4.3% | 7.3% | +1.9% |
| GCOGenesco Inc. | $406M | $36.51 | 9.0 | 0.4 | 0.7 | 0.0% | 1.7% | 2.5% | 3.0% | +39.6% |
| EIKNEikon Therapeutics, Inc. Common Stock | $404M | $7.47 | loss | — | 0.9 | 0.0% | — | −46.2% | — | −50.2% |
| BMMBlue Moon Metals Inc. | $404M | $4.87 | loss | — | 1.8 | 0.0% | — | −23.0% | — | +7.7% |
| ADVAdvantage Solutions Inc. | $403M | $30.28 | loss | 0.5 | 1.0 | 0.0% | −7.6% | 3.5% | 2.2% | −18.2% |
| USCBUSCB Financial Holdings, Inc. | $403M | $22.04 | 14.4 | n/a | 1.7 | 2.2% | 19.9% | n/a | −5.1% | +34.1% |
| VHIValhi, Inc. | $402M | $14.21 | loss | 0.4 | 0.4 | 2.3% | −1.8% | −0.3% | 3.4% | +3.3% |
| SAVSaratoga Investment Corp 7.50% | $402M | $24.85 | — | — | — | 1.9% | — | — | — | −0.8% |
| LSAKLesaka Technologies, Inc. | $402M | $4.68 | 119 | — | 1.3 | 0.0% | 0.4% | 2.2% | −0.2% | +13.6% |
| URGUr-Energy Inc. | $401M | $1.01 | loss | 10.8 | 5.8 | 0.0% | −252% | −31.8% | −11.2% | −48.2% |
| VITLVital Farms, Inc. | $400M | $9.33 | loss | 0.6 | 1.4 | 0.0% | 0.0% | 0.0% | 16.4% | −78.5% |
| STRZStarz Entertainment Corp. | $399M | $23.79 | loss | 0.8 | 1.4 | 0.0% | −34.0% | −19.3% | −51.7% | +96.3% |
| RWTRedwood Trust, Inc. | $398M | $3.17 | loss | n/a | 0.4 | 22.7% | 0.6% | n/a | 51.2% | −42.9% |
| AACAres Acquisition Corp. III Class A | $398M | $10.07 | loss | — | neg. eq. | 0.0% | — | −11.9% | — | −0.8% |
| CINTCI&T Inc | $398M | $3.09 | 11.0 | 0.9 | 1.2 | 0.0% | 6.8% | 8.1% | −44.0% | −22.6% |
| ISTRInvestar Holding Corporation | $396M | $28.82 | 11.1 | n/a | 1.0 | 1.6% | 17.8% | n/a | 22.1% | +30.3% |
| TLRYTilray Brands, Inc. | $396M | $3.54 | loss | 0.4 | 0.3 | 0.0% | −16.8% | −4.1% | −3.0% | −79.4% |
| PCBPCB Bancorp | $395M | $27.73 | 9.5 | n/a | 1.0 | 3.1% | 19.7% | n/a | 6.3% | +39.8% |
| ATNIATN International, Inc. | $392M | $25.49 | 2.4 | 1.0 | 0.7 | 4.4% | 22.6% | 14.2% | 2.0% | +79.8% |
| CARLCarlsmed, Inc. | $392M | $14.42 | loss | 5.8 | 4.7 | 0.0% | −57.4% | −36.3% | 65.4% | +9.9% |
| SRTAStrata Critical Medical, Inc. | $392M | $4.53 | 9.1 | 1.5 | 1.4 | 0.0% | 15.7% | −7.1% | 0.6% | −3.8% |
| ARCTArcturus Therapeutics Holdings Inc. | $391M | $13.74 | loss | 9.3 | 2.3 | 0.0% | −392% | −53.0% | −79.1% | −27.5% |
| BOCBoston Omaha Corporation | $389M | $12.89 | loss | 4.4 | 0.8 | 0.0% | −12.1% | −0.7% | −2.4% | −6.7% |
| CYHCommunity Health Systems, Inc. | $389M | $2.76 | loss | 0.5 | neg. eq. | 0.0% | −1.3% | −84.4% | 77.2% | −4.8% |
| JMIAJumia Technologies AG | $389M | $6.28 | loss | 1.7 | 438 | 0.0% | −27.5% | −363% | 27.7% | −45.9% |
| CHCTCommunity Healthcare Trust Incorporated | $389M | $13.61 | 20.3 | 7.6 | 0.9 | 13.0% | 16.9% | 4.8% | 5.4% | +2.3% |
| KYTXKyverna Therapeutics, Inc. | $388M | $6.39 | loss | — | 2.4 | 0.0% | — | −80.0% | — | −3.6% |
| RMNIRimini Street, Inc. | $388M | $4.16 | 50.3 | 0.8 | neg. eq. | 0.0% | 1.7% | 15.5% | 0.6% | −2.8% |
| CHMGChemung Financial Corporation | $388M | $80.54 | 11.6 | n/a | 1.4 | 1.7% | 24.2% | n/a | 2.2% | +60.6% |
| ALTIAlTi Global, Inc. | $388M | $2.61 | loss | 1.6 | 0.4 | 0.0% | −40.7% | −8.0% | 28.4% | −27.3% |
| VGZVista Gold Corp. | $387M | $2.65 | loss | — | 7.6 | 0.0% | — | −21.0% | — | +28.6% |
| MRAMEverspin Technologies, Inc. | $386M | $16.45 | loss | 5.5 | 5.4 | 0.0% | −4.2% | −12.7% | 20.9% | +55.0% |
| FCBMFirst Carolina Financial Services | $385M | $12.74 | 31.9 | n/a | 0.7 | 0.0% | 10.6% | n/a | 196% | +1.1% |
| SLIStandard Lithium Ltd. | $385M | $1.58 | loss | — | 1.0 | 0.0% | — | 6.7% | — | −65.0% |
| NFGCNew Found Gold Corp | $385M | $1.57 | — | — | — | 0.0% | — | — | — | −35.9% |
| FRPHFRP Holdings, Inc. | $384M | $20.04 | 3781 | 11.5 | 0.9 | 0.0% | 0.2% | 0.5% | 2.5% | −16.6% |
| IRDOpus Genetics, Inc. | $384M | $4.65 | loss | 33.5 | neg. eq. | 0.0% | −1092% | −59.3% | −36.1% | +137% |
Showing 3,201–3,250 of 5,450
A blank means a figure isn't reported or doesn't mean anything for that company: there's no P/E for a company losing money, no EV/Sales for a bank, no P/B when a company owes more than it owns. A filter on that figure leaves the company out. Growth compares the last twelve months with the twelve before. Figures describe the companies; they aren't advice to buy or sell anything.